Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 3/20 | 0.63 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.62 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.61 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.61 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.61 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.56 |
| ▸ | DHODH | Q02127 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9222333 | 0.98 | MCL1 (0.62) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL12584388 | 0.90 | NR4A2 (0.61) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL4964238 | 0.88 | PARP10 (0.63) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL9222322 | 0.88 | GSTP1 (0.59) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL22664706 | 0.85 | GSTP1 (0.56) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL28493306 | 0.84 | MEN1 (0.64) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL28247966 | 0.84 | LTB4R2 (0.48) | MCL1FFAR4 | |
| SCHEMBL7743316 | 0.84 | MRGPRX4 (0.60) | MCL1NR4A2SRD5A2DHODHMAOB | |
| SCHEMBL11593773 | 0.83 | P2RY14 (0.60) | MCL1GSTP1NR4A2NR4A1NR4A3 | |
| SCHEMBL7080517 | 0.83 | P2RY14 (0.60) | MCL1GSTP1NR4A2NR4A1NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| EP-0405983-A2 | Optically active substance and liquid crystal composition | MITSUBISHI RAYON CO., LTD (JP) | 1991-01-02 | — | — | EP | disclosed |
| US-4080471-A | ANTIARRYTHMIA | AKTIEBOLAGET HASSLE (SW) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | MCL1 2821/4885GSTP1 1370/4885NR4A2 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.